• Olsalazine Sodium: Applied Workflows in Tumor and Xenobiotic

  2026-05-07

  Olsalazine Sodium, a mesalamine dimer and potent LTB4 chemotaxis inhibitor, is redefining both cancer and vector biology assays with its unique solubility and bioactivity profile. This guide translates cutting-edge findings into actionable workflows, protocol refinements, and troubleshooting strategies for advanced research.

• Fucoidan as a Chemoprotective Agent: Gut–Liver Axis Insights

  2026-05-06

  Explore how Fucoidan, a potent sulfated α-L-fucan, protects against chemotherapy-induced steatohepatitis via gut–liver axis modulation. This article offers unique protocol guidance and mechanistic clarity for researchers seeking a credible, chemoprotective polysaccharide.

• Imatinib (STI571): Advanced Modeling of Tyrosine Kinase Path

  2026-05-06

  Explore how Imatinib (STI571) advances signal transduction research and cancer biology through precise tyrosine kinase pathway inhibition. This article uniquely integrates the latest assembloid modeling insights to guide more predictive preclinical studies.

• Protoporphyrin IX (SKU B8225): Precision in Cell Viability A

  2026-05-05

  This article addresses core laboratory challenges in cell viability and ferroptosis research, demonstrating how Protoporphyrin IX (SKU B8225) from APExBIO delivers reproducible, high-purity results. Scenario-driven Q&As provide practical guidance for biomedical researchers, optimizing assay design and data reliability with evidence-backed recommendations.

• Disodium Bicinchoninate (SKU C6645): Reliable Aqueous Reagen

  2026-05-05

  This article delivers scenario-driven, evidence-based guidance for implementing Disodium bicinchoninate (SKU C6645) in demanding cell viability, proliferation, and cytotoxicity workflows. We address common laboratory pitfalls—such as inconsistent assay data and solvent incompatibility—by analyzing how this water-soluble, high-purity molecular biology reagent from APExBIO provides reproducibility and practical workflow advantages.

• Reliable iNOS Inhibition: PPM-18 (N-(1,4-dihydro-1,4-dioxo-2

  2026-05-04

  This article explores practical laboratory strategies for cell viability and inflammation research using PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide), SKU C4074. Drawing on real-world scenarios, quantitative data, and validated protocols, it demonstrates how APExBIO’s PPM-18 offers reproducible, sensitive NF-κB/iNOS pathway inhibition for advanced sepsis and immune modulation studies.

• Levofloxacin: Translational Leverage Beyond Antibacterial Ac

  2026-05-04

  This thought-leadership article examines the dual utility of Levofloxacin, a synthetic fluoroquinolone antibiotic, in both antibacterial pathway interrogation and bone/cartilage cell modulation. Building on mechanistic and preclinical insights, we provide strategic guidance for translational researchers to optimize Levofloxacin’s application in advanced assays, while addressing resistance, methodological rigor, and emerging research frontiers.

• Dihydrotestosterone (DHT) in Cancer Signaling and Resistance

  2026-05-03

  Dihydrotestosterone (DHT) empowers researchers to probe androgen receptor and EGFR/ERBB2 pathways in advanced cancer models, supporting both mechanistic discovery and translational innovation. This article guides you from protocol setup through troubleshooting, with actionable insights rooted in recent resistance biology.

• Lypressin Acetate: Reliable Solutions for Lab Assays (SKU N2

  2026-05-02

  This article provides scenario-driven, evidence-based guidance for leveraging Lypressin acetate (SKU N2888) in cell viability, proliferation, and cytotoxicity assays. It addresses real laboratory challenges, quantifies performance parameters, and demonstrates why researchers can trust APExBIO’s rigorous formulation for reproducible and translational outcomes.

• Multi-Omics Dissects ARID1A-Driven Resistance to Vemurafenib

  2026-05-02

  This study leverages integrative multi-omics to map early and long-term drug response networks in BRAF V600E melanoma, revealing how ARID1A loss rewires signaling to drive resistance and immune evasion. The findings highlight new resistance nodes and provide a framework for refining targeted and immunotherapy strategies.

• Luminescent ATP Detection Assay Kit: Precision in Energy Map

  2026-05-01

  Unlocking reproducible ATP quantification, the Luminescent ATP Detection Assay Kit leverages firefly luciferase for sensitive, scalable detection in diverse biomedical workflows. Its streamlined protocol and compatibility with downstream analyses set a new benchmark for energy metabolism assays—crucial in translational disease research.

• CDK4/6 and BET Inhibition Synergizes to Suppress PDAC via EM

  2026-04-30

  Gu et al. (2025) demonstrate that combined CDK4/6 and BET inhibition robustly suppresses pancreatic ductal adenocarcinoma (PDAC) growth and reverses EMT by modulating GSK3β-mediated Wnt/β-catenin and TGF-β/Smad signaling. This mechanistic synergy suggests new therapeutic strategies and highlights the importance of precisely targeting signaling crosstalk in aggressive cancers.

• Y-27632 ROCK Inhibitor: Applied Workflows for Cytoskeletal R

  2026-04-30

  Unlock precise cytoskeletal modulation and dissect ROCK signaling pathways with Y-27632 from APExBIO. This guide translates cutting-edge research into actionable protocols, advanced applications, and troubleshooting strategies for cell-based assays and regenerative workflows.

• HOXB4-Enhanced BMSCs Protect Endothelium via Wnt/β-Catenin i

  2026-04-29

  This study demonstrates that HOXB4 overexpression in bone marrow mesenchymal stem cells (BMSCs) confers significant protection to endothelial cells against LPS-induced acute lung injury (ALI) through activation of the Wnt/β-catenin pathway. Functional reversal by XAV-939 establishes a causal link, highlighting a mechanistic target for optimizing stem cell-based ALI therapies.

• Organic Cation Transporter Responses to Dye Exposure in Aede

  2026-04-29

  Kennel and Rouhier's 2025 study advances our understanding of how Aedes aegypti mosquitoes process xenobiotics by investigating organic cation transporter expression following synthetic dye exposure. Their findings suggest that while transporter gene expression remains largely unchanged, the molecular structure of xenobiotics significantly affects excretion patterns and mosquito survival—offering new molecular targets for vector control.

450 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page